(DBXJ) Xtrackers - MSCI Japan - Ratings and Ratios
ETF, Japan, Equity, Morningstar, Index
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 17.0% |
| Value at Risk 5%th | 24.9% |
| Relative Tail Risk | -11.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | 4.68 |
| CAGR/Max DD | 0.77 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.383 |
| Beta | 0.174 |
| Beta Downside | 0.444 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.96% |
| Mean DD | 3.68% |
| Median DD | 2.96% |
Description: DBXJ Xtrackers - MSCI Japan November 12, 2025
The Xtrackers MSCI Japan UCITS ETF (ticker DBXJ) is a German-registered exchange-traded fund that tracks the Morningstar Japan Total Market Net Return Index (JPY-denominated). It falls under the “Japan Large-Cap Blend Equity” category, offering investors exposure to a broad basket of Japanese equities.
As of the latest data (Q3 2024), DBJX carries an expense ratio of roughly 0.20% and manages about €320 million in assets. Its top holdings are dominated by the country’s export-oriented giants-Toyota Motor Corp., Sony Group Corp., and SoftBank Group Corp.-which together account for roughly 15% of the portfolio. The fund’s performance is closely tied to two macro drivers: the Bank of Japan’s ultra-low-rate policy, which supports corporate earnings, and the yen’s depreciation, which boosts the overseas revenue of Japanese exporters. Recent quarterly reports show a dividend yield near 2.1%, reflecting the relatively high payout ratios of these mature conglomerates.
For a deeper quantitative breakdown of DBXJ’s risk-adjusted metrics and scenario analysis, the ValueRay platform provides a useful, data-driven view.
What is the price of DBXJ shares?
Over the past week, the price has changed by +0.26%, over one month by +1.00%, over three months by +5.04% and over the past year by +10.38%.
Is DBXJ a buy, sell or hold?
What are the forecasts/targets for the DBXJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 94.3 | 9.6% |
DBXJ Fundamental Data Overview December 29, 2025
Market Cap EUR = 1.76b (1.76b EUR * 1.0 EUR.EUR)
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.76b EUR (1.76b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.76b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.76b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.65% (E(1.76b)/V(1.76b) * Re(6.65%) + (debt-free company))
Discount Rate = 6.65% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)